Alocuro – A Complete Regenerative Platform
Within Australia, Alocuro's platelet-concentrating medical devices are supplied to registered medical and dental practitioners, in accordance with TGA regulations governing autologous biological products. Devices are listed on the ARTG (Australian Register of Therapeutic Goods).
While registered nurses or nurse practitioners can perform PRP procedures, as included in their insured scope of practice, this must occur under the clinical oversight of a supervising doctor or dentist, who retains professional responsibility for patient care and outcomes - consistent with TGA guidelines.
Device Features at a Glance
Alocuro PRP and PRF preparation systems are engineered to support consistent output and workflow efficiency:
High platelet capture
Designed to support elevated platelet recovery across a range of baseline counts.
Adjustable concentration and leukocyte inclusion
Flexible output control aligns preparation profile with indication-specific protocol frameworks.
Multiple device formats
Available in 10 mL, 15 mL, 20 mL, 30 mL and 60 mL kit sizes to match clinical workflow needs.
Closed, gel-free workflow
A sealed preparation process supports aseptic handling and reduces variability.
Single platform for PRP and PRF
The same system supports a range of autologous preparations without additional specialised equipment.
Centrifuges
AL416 Centrifuge: Compatible with all device sizes
Required for Leukocyte-reduced PRP protocols
AL1015 Centrifuge: Compact option for 10ml & 15ml devices
Used for PRP & PRF treatments, except for joint & tendon protocols
Manufacturing & Quality Standards
Alocuro devices are ARTG-listed and manufactured under ISO quality management standards. Devices are single-use, sterile and designed for clinical preparation of platelet-rich plasma and platelet-rich fibrin, from the patient’s blood components, at the point-of-care. In line with TGA regulation of blood components, the patient’s biological material is never stored for use at a later time
Performance & Validation
Independent testing by Australian pathology laboratories has demonstrated that Alocuro systems support consistently high platelet capture and flexible output profiles, including adjustable leukocyte content. This performance supports clinicians in aligning preparation output with indication-specific protocol considerations.
Note: Preparation metrics and output characteristics depend on baseline platelet counts, protocol parameters and clinician handling.
Why Choose Alocuro?
Alocuro devices are developed to support clinicians with:
Reproducible separation and high platelet recovery
Adjustable output control for differing clinical contexts
A single platform for PRP, PRF and autologous workflows
Multiple kit sizes for scalability and workflow alignment
Clinician preference, protocol design and clinical indication determine component parameter selection.